These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


464 related items for PubMed ID: 16343498

  • 21. Randomized controlled trial comparing 200μg and 400μg sublingual misoprostol for prevention of primary postpartum hemorrhage.
    Ugwu IA, Oluwasola TA, Enabor OO, Anayochukwu-Ugwu NN, Adeyemi AB, Olayemi OO.
    Int J Gynaecol Obstet; 2016 May; 133(2):173-7. PubMed ID: 26892695
    [Abstract] [Full Text] [Related]

  • 22. Active Management of the Third Stage of Labor With a Combination of Oxytocin and Misoprostol to Prevent Postpartum Hemorrhage: A Randomized Controlled Trial.
    Quibel T, Ghout I, Goffinet F, Salomon LJ, Fort J, Javoise S, Bussieres L, Aegerter P, Rozenberg P, Groupe de Recherche en Obstétrique et Gynécologie (GROG).
    Obstet Gynecol; 2016 Oct; 128(4):805-11. PubMed ID: 27607864
    [Abstract] [Full Text] [Related]

  • 23. Adjunctive rectal misoprostol versus oxytocin infusion for prevention of postpartum hemorrhage in women at risk: a randomized controlled trial.
    Badejoko OO, Ijarotimi AO, Awowole IO, Loto OM, Badejoko BO, Olaiya DS, Fatusi AO, Kuti O, Orji EO, Ogunniyi SO.
    J Obstet Gynaecol Res; 2012 Nov; 38(11):1294-301. PubMed ID: 22612662
    [Abstract] [Full Text] [Related]

  • 24. A comparison of rectal misoprostol and intravenous oxytocin on hemorrhage and homeostatic changes during cesarean section.
    Fazel MR, Mansoure-Samimi, Esmaeil-Fakharian.
    Middle East J Anaesthesiol; 2013 Feb; 22(1):41-6. PubMed ID: 23833849
    [Abstract] [Full Text] [Related]

  • 25. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial.
    Atukunda EC, Siedner MJ, Obua C, Mugyenyi GR, Twagirumukiza M, Agaba AG.
    PLoS Med; 2014 Nov; 11(11):e1001752. PubMed ID: 25369200
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Misoprostol versus oxytocin for the reduction of postpartum blood loss.
    Baskett TF, Persad VL, Clough HJ, Young DC.
    Int J Gynaecol Obstet; 2007 Apr; 97(1):2-5. PubMed ID: 17321529
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A randomized controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum hemorrhage.
    Priya GP, Veena P, Chaturvedula L, Subitha L.
    Arch Gynecol Obstet; 2015 Dec; 292(6):1231-7. PubMed ID: 25990482
    [Abstract] [Full Text] [Related]

  • 30. The effect of intrauterine misoprostol on blood loss during caesarean section.
    Bahadur A, Khoiwal K, Bhattacharya N, Chaturvedi J, Kumari R.
    J Obstet Gynaecol; 2019 Aug; 39(6):753-756. PubMed ID: 31010345
    [Abstract] [Full Text] [Related]

  • 31. The efficacy of intrauterine misoprostol during cesarean section in prevention of primary PPH, a randomized controlled trial.
    Alalfy M, Lasheen Y, Elshenoufy H, Elzahaby IM, Kaleem HW, El Sawah H, Azkalani A, Saber W, Rashwan ASSA.
    J Matern Fetal Neonatal Med; 2020 May; 33(9):1459-1465. PubMed ID: 30176758
    [Abstract] [Full Text] [Related]

  • 32. The effect of post-cesarean rectal misoprostol on intestinal motility.
    Adanikin AI, Orji EO, Fasubaa OB, Onwudiegwu U, Ijarotimi OA, Olaniyan O.
    Int J Gynaecol Obstet; 2012 Nov; 119(2):159-62. PubMed ID: 22925817
    [Abstract] [Full Text] [Related]

  • 33. Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage.
    Nasr A, Shahin AY, Elsamman AM, Zakherah MS, Shaaban OM.
    Int J Gynaecol Obstet; 2009 Jun; 105(3):244-7. PubMed ID: 19249048
    [Abstract] [Full Text] [Related]

  • 34. Prevention of postpartum haemorrhage with sublingual misoprostol or oxytocin: a double-blind randomised controlled trial.
    Bellad MB, Tara D, Ganachari MS, Mallapur MD, Goudar SS, Kodkany BS, Sloan NL, Derman R.
    BJOG; 2012 Jul; 119(8):975-82; discussion 982-6. PubMed ID: 22703421
    [Abstract] [Full Text] [Related]

  • 35. Buccal misoprostol to prevent hemorrhage at cesarean delivery: a randomized study.
    Hamm J, Russell Z, Botha T, Carlan SJ, Richichi K.
    Am J Obstet Gynecol; 2005 May; 192(5):1404-6. PubMed ID: 15902121
    [Abstract] [Full Text] [Related]

  • 36. Rectal vs. sublingual misoprostol before cesarean section: double-blind, three-arm, randomized clinical trial.
    Sweed MS, El-Saied MM, Abou-Gamrah AE, El-Sabaa HA, Abdel-Hamid MM, Hemeda H, Mansour AM, Shawky ME, El-Sayed MA, Mohamed RM.
    Arch Gynecol Obstet; 2018 Dec; 298(6):1115-1122. PubMed ID: 30291483
    [Abstract] [Full Text] [Related]

  • 37. A randomized, controlled trial comparing effect of oral misoprostol and intravenous syntocinon on intra-operative blood loss during cesarean section.
    Acharya G, Al-Sammarai MT, Patel N, Al-Habib A, Kiserud T.
    Acta Obstet Gynecol Scand; 2001 Mar; 80(3):245-50. PubMed ID: 11207490
    [Abstract] [Full Text] [Related]

  • 38. Misoprostol for prevention of postpartum hemorrhage.
    Bugalho A, Daniel A, Faúndes A, Cunha M.
    Int J Gynaecol Obstet; 2001 Apr; 73(1):1-6. PubMed ID: 11336714
    [Abstract] [Full Text] [Related]

  • 39. Randomized double-blind placebo-controlled trial of buccal misoprostol to reduce the need for additional uterotonic drugs during cesarean delivery.
    Hernández-Castro F, López-Serna N, Treviño-Salinas EM, Soria-López JA, Sordia-Hernández LH, Cárdenas-Estrada E.
    Int J Gynaecol Obstet; 2016 Feb; 132(2):184-7. PubMed ID: 26534874
    [Abstract] [Full Text] [Related]

  • 40. Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section.
    Boucher M, Horbay GL, Griffin P, Deschamps Y, Desjardins C, Schulz M, Wassenaar W.
    J Perinatol; 1998 Feb; 18(3):202-7. PubMed ID: 9659650
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 24.